Hair loss

Pelage Pharmaceuticals Announces $16.75M Series A Financing led by GV to Revolutionize Regenerative Medicine for Hair Loss

Retrieved on: 
Tuesday, February 27, 2024
MPC, Woman, CMO, LOS, Hair loss, GV, Pattern hair loss, Hospital, Fur, Harvard University, Faculty, University, YK, Massachusetts General Hospital, Harvard Medical School, DRS, American Academy, Pharmaceutical industry

LOS ANGELES , Feb. 27, 2024 /PRNewswire/ -- Pelage Pharmaceuticals, a clinical-stage regenerative medicine company pioneering a new generation of treatments for hair loss, announced today that the company has closed a $16.75 million Series A financing led by GV with participation from Main Street Advisors, Visionary Ventures and YK BioVentures, to advance a first-in-class treatment for androgenetic alopecia or pattern baldness, and other types of alopecia including chemotherapy-induced hair loss.

Key Points: 
  • Additionally, PP405 may also have applications for other types of hair loss such as telogen effluvium (stress-induced hair loss) and chemotherapy-induced hair loss.
  • "What we've observed is that in people who experience hair loss, the actual hair follicle stem cells are still present but have reverted to a dormant state.
  • "Hair loss is an incredibly common health problem with few effective solutions," said Cathy Friedman, Executive Venture Partner, GV and Board Director, Pelage Pharmaceuticals.
  • Pelage is built on rigorous science and offers the opportunity to target the follicle stem cells directly," said Dr. Weng.

LIM College Announces Annual Student-Produced Fashion Show will be April 19 at the Glasshouse in NYC

Retrieved on: 
Monday, February 26, 2024
Special, Hair loss, LIM College, Bloomingdale's, Learning, Kickstarter, Content, Mentorship, Organization, Patient, LIM, Knowledge, Glass house, Cancer, Student

NEW YORK, Feb. 26, 2024 /PRNewswire/ -- LIM College today announced that its annual student-produced fashion show will be held April 19 at 6 p.m. at New York City's famed Glasshouse at 660 12th Ave.

Key Points: 
  • "The 2024 LIM Fashion Show will be unlike any event our students have produced in nearly eight decades," said Ron Marshall, LIM College President.
  • This includes not only top students in the business of fashion at LIM, but also emerging local design talent in New York.
  • Any industry organization that wants to tap into who and what is next within fashion will find value in attending this year's LIM Fashion Show," Marshall added.
  • Planning for the LIM Fashion Show is ongoing and designers, industry leaders, brands, retailers, and those interested in being involved in the event or sponsoring it may contact Consulting Fashion Show Producer Rachel Willingham at [email protected].

FDA Approves First Cellular Therapy to Treat Patients with Unresectable or Metastatic Melanoma

Retrieved on: 
Friday, February 16, 2024
Human services, BRAF, Skin cancer, Neoplasm, Fever, Immune system, Melanoma, Cosmetics, Multimedia, Febrile neutropenia, Immunotherapy, Diarrhea, Hair loss, Dietary supplement, FDA, Food, Infection, Growth, Swelling, Tachycardia, PD-1, Edema, Cell, Hypoxia, Vaccine, Risk, Antibody, Animal, Metastasis, Safety, Heated tobacco product, Fatigue, Accelerated approval (FDA), Death, Rash, Public, BRAF V600, Patient, Protein, Chills, Sunlight, Hypotension, MEK, Cancer, Pharmaceutical industry

"Unresectable or metastatic melanoma is an aggressive form of cancer that can be fatal," said Peter Marks, M.D., Ph.D., director of the FDA's Center for Biologics Evaluation and Research (CBER).

Key Points: 
  • "Unresectable or metastatic melanoma is an aggressive form of cancer that can be fatal," said Peter Marks, M.D., Ph.D., director of the FDA's Center for Biologics Evaluation and Research (CBER).
  • Melanoma can spread to other parts of the body if not detected and treated early, resulting in metastatic disease.
  • Treatment for unresectable or metastatic melanoma may include immunotherapy using PD-1 inhibitors, which are antibodies targeting certain proteins in the body to help the immune system fight off cancer cells.
  • Those patients whose melanoma has progressed with these therapies have a high unmet medical need.

Zocdoc Introduces Guided Search, Helping Patients More Confidently Connect with the Right Providers

Retrieved on: 
Tuesday, February 13, 2024
Hair loss, Communication, ESOMAR, Patient, Panic, Market Research Society, Ageing, Dermatology, Insurance, Nursing

NEW YORK, Feb. 13, 2024 /PRNewswire/ -- Zocdoc, the leading healthcare marketplace that makes it easy for patients to find and book in-person or virtual care across over 250 specialties and more than 18,000 insurance plans, today introduced Guided Search. This new search experience intuitively provides patients with a more tailored set of results based on their unique care needs so they can select the right provider and book with greater confidence.

Key Points: 
  • Guided Search aims to take the guesswork out of the decision-making process for patients, and it improves the fit of new patients coming to a provider's practice.
  • With Guided Search, patients no longer need to know whether they're seeking, for example, a psychologist versus psychiatrist, or an optometrist versus ophthalmologist.
  • In particular, Guided Search:
    Increases bookings from patients that providers are able to treat by highlighting all of a providers' areas of care, helping practices reach the patients they want.
  • Zocdoc directly invited healthcare providers on its marketplace to participate in a survey, and nearly 1,000 providers (971) responded.

Nextdoor Reveals the Winners for the 2024 #LoveYourNeighborhood Photo Contest, Following A Record-Breaking Number of Entries

Retrieved on: 
Thursday, February 8, 2024
Apps, Applications, Technology, Arts, Museums, Entertainment, Photography, Communications, Other Entertainment, Internet, Social Media, Multimedia, Brilliant, Restaurant, ARV, Red Wagon, Friends, Animal, Hair loss, Pet, Cape Cod, Mayflower, General store

Today, Nextdoor (NYSE: KIND), the neighborhood network, announced the winners of the latest - and largest - #LoveYourNeighborhood photo competition to date.

Key Points: 
  • Today, Nextdoor (NYSE: KIND), the neighborhood network, announced the winners of the latest - and largest - #LoveYourNeighborhood photo competition to date.
  • “It was low tide,” said Deb Gaston, grand prize winner of the #LoveYourNeighborhood photo contest 2024.
  • “Shelby and I were alone somewhere between the beautiful bayside beaches of Chapin and Mayflower on Cape Cod.
  • Two additional runner-up winners, Sharon Smith of the Rose Garden, California Nextdoor neighborhood and David Swanson of the Willow Lake, Arizona Nextdoor neighborhood received the second and third-most votes.

Zylö’s ‘Powered by Z-pods®’ technology incorporated into BosleyMD’s new product line

Retrieved on: 
Tuesday, February 6, 2024
Foam, Intelligence, Cable television, Male, CVS, Walmart, Hair loss, Y100, Pattern hair loss, Skin, Mouse, Ulta Beauty, Female, Sale, Nature, Advertising

GREENVILLE, SC, Feb. 06, 2024 (GLOBE NEWSWIRE) -- Zylö’s Z-pod® topical delivery platform is being used by BosleyMD—the Thinning Hair Authority™—as a key feature in their newly launched product line, Revive+ Densifying Foam. BosleyMD is currently offering a male version and a female version through CVS and online (see link below); distribution through Walmart and Ulta Beauty is expected soon. Cable TV and online advertising will be used to promote the products.

Key Points: 
  • As explained on the back of the Revive+ package, Zylö’s technology provides SUPERIOR SUSTAINED DELIVERY, with the tagline: Encapsulated for precise delivery to the follicles and sustained release up to 24 hours.
  • The Z-pods also provide enhanced delivery to hair follicles, perfect for a hair-growth product.
  • With the Revive+ product line, the Z-pods encapsulate the active ingredient Y100, a natural ingredient that is extracted and purified from the alma tree.
  • Scott Pancoast CEO + founder of Zylö, stated, "Congratulations to YuvaBio and BosleyMD for the successful launch of the Revive+ product line.

Stemson Therapeutics Announces Technological Breakthrough in New Hair Growth

Retrieved on: 
Tuesday, February 6, 2024
Science, Biotechnology, Research, Pharmaceutical, Health, FDA, Clinical Trials, Other Health, Multimedia, Anxiety, GFP, Cell, Machine learning, Hair loss, Patient, Transplant, Big data, EFU, Skin, Mouse, Depression, Therapy, Quality of life, Pattern hair loss, Medicine, Algorithm, Doctor of Philosophy, Data science, Wool

Stemson Therapeutics today announced a major technological advance that clears the path for its proprietary hair rejuvenation solution to advance toward human clinical trials.

Key Points: 
  • Stemson Therapeutics today announced a major technological advance that clears the path for its proprietary hair rejuvenation solution to advance toward human clinical trials.
  • Stemson is developing an iPSC-derived autologous cell therapy to regenerate healthy hair follicles and has successfully created human hair follicles in humanized mice using engineered follicular units.
  • C. Enlarged image of hair bulb demonstrating green fluorescent protein (GFP) labelled cells from Stemson EFUs are responsible for generating human hair follicles in skin pad.
  • “Stemson is poised to deliver truly novel and effective hair growth treatments to hair loss patients.

Wingderm® "Dual Innovation, Infinite Possibilities" Global Distributor conference was successfully held at IMCAS

Retrieved on: 
Monday, February 5, 2024
World Congress, Intelligence, PDO, Hair loss, Exhibition, Pigment, Botulinum toxin, Certificate, Infinite Possibilities

BEIJING, Feb. 5, 2024 /PRNewswire/ -- IMCAS World Congress 2024 was held in Paris, France from February 1st to 3rd.

Key Points: 
  • BEIJING, Feb. 5, 2024 /PRNewswire/ -- IMCAS World Congress 2024 was held in Paris, France from February 1st to 3rd.
  • On the first day, Wingderm® successfully held the "Dual Innovation, Infinite Possibilities" new device release conference for its signed distributors worldwide, along with Renuva® upgrade presentation and clinical application sharing session, which was a complete success.
  • Lasermach 2 is expected to be a highly competitive hair removal device in the next few years.
  • During the 3-day exhibition, Wingderm® showcased a lot of devices, with Lasermach 2 and the upgraded Renuva® garnering significant interest.

Wingderm® "Dual Innovation, Infinite Possibilities" Global Distributor conference was successfully held at IMCAS

Retrieved on: 
Monday, February 5, 2024
World Congress, Intelligence, PDO, Hair loss, Exhibition, Pigment, Botulinum toxin, Certificate, Infinite Possibilities

BEIJING, Feb. 5, 2024 /PRNewswire/ -- IMCAS World Congress 2024 was held in Paris, France from February 1st to 3rd.

Key Points: 
  • BEIJING, Feb. 5, 2024 /PRNewswire/ -- IMCAS World Congress 2024 was held in Paris, France from February 1st to 3rd.
  • On the first day, Wingderm® successfully held the "Dual Innovation, Infinite Possibilities" new device release conference for its signed distributors worldwide, along with Renuva® upgrade presentation and clinical application sharing session, which was a complete success.
  • Lasermach 2 is expected to be a highly competitive hair removal device in the next few years.
  • During the 3-day exhibition, Wingderm® showcased a lot of devices, with Lasermach 2 and the upgraded Renuva® garnering significant interest.

Personalized Skincare Brand Curology Launches Into Hair Care Category With Hair Formula Rx

Retrieved on: 
Thursday, February 1, 2024
Nursing, SAN, Male, Life, DOS, Science, Fear, Hair loss, Patient, Spironolactone, Dermatology, MD, Skin, NPS, Female, PAS, Finasteride, Minoxidil, Scalp, Cosmetics

SAN FRANCISCO, Feb. 1, 2024 /PRNewswire/ -- Dermatologist-powered personalized skincare brand Curology announced today their launch into the hair care category with its latest innovation, Hair FormulaRx. This personalized prescription hair growth treatment contains clinically proven ingredients that help to regrow hair in as little as three months.*

Key Points: 
  • SAN FRANCISCO, Feb. 1, 2024 /PRNewswire/ -- Dermatologist-powered personalized skincare brand Curology announced today their launch into the hair care category with its latest innovation, Hair FormulaRx.
  • This personalized prescription hair growth treatment contains clinically proven ingredients that help to regrow hair in as little as three months.
  • If topical minoxidil is included in one's Hair FormulaRx, Curology offers higher strengths of minoxidil than what's available over-the-counter.
  • It's a leave-on topical hair solution that addresses multiple root causes of hair thinning for visibly thicker, stronger hair.